STOCKWATCH
·
Pharmaceuticals
Joint Venture8 Sept 2025, 08:01 pm

Morepen Laboratories Subsidiary Executes Joint Venture Agreement

AI Summary

Morepen Laboratories Ltd. announced that its subsidiary, Morepen Medipath Limited, has entered into a joint venture agreement with Bimedical FZE. The new joint venture company, yet to be named and incorporated, will carry on the business of manufacturing, trading, and selling medical devices related products. Morepen Laboratories will hold 30% shares of the proposed JVC indirectly through its subsidiary.

Key Highlights

  • Morepen Medipath Limited has executed a joint venture agreement with Bimedical FZE.
  • The new joint venture company will manufacture, trade, and sell medical devices related products.
  • Morepen Laboratories will hold 30% shares of the proposed JVC indirectly through its subsidiary.
MOREPENLAB
Pharmaceuticals
MOREPEN LABORATORIES LTD.

Price Impact